Stocktoria
MERIT MEDICAL SYSTEMS INC MMSI
MERIT MEDICAL SYSTEMS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $1.3B | $1.2B | $1.1B | $963.9M | $994.9M | $882.8M | $727.9M | $603.8M |
| Gross profit | $738.3M | $643.3M | $583.9M | $519.1M | $485.3M | $401.2M | $432.4M | $394.8M | $326.3M | $265.0M |
| R&D expense | — | — | — | — | — | — | — | $59.5M | $51.4M | $45.2M |
| SG&A expense | $455.2M | $399.7M | $373.7M | $342.5M | $335.7M | $297.7M | $327.3M | $276.0M | $229.1M | $184.4M |
| Operating income | $184.7M | $155.7M | $123.9M | $87.6M | $60.9M | -$1.6M | $15.4M | $58.6M | $33.1M | $34.9M |
| Interest expense | — | — | $15.5M | $6.3M | $5.3M | $10.0M | $12.4M | $10.4M | $7.7M | $8.8M |
| Income tax | $42.4M | $29.6M | $17.7M | $8.1M | $5.5M | -$3.4M | -$3.3M | $7.5M | $8.4M | $5.3M |
| Net income | $128.5M | $120.4M | $94.4M | $74.5M | $48.5M | -$9.8M | $5.5M | $42.0M | $27.5M | $20.1M |
| EPS (diluted) | $2.13 | $2.03 | $1.62 | $1.29 | $0.84 | $-0.18 | $0.10 | $0.78 | $0.55 | $0.45 |
| Operating cash flow | $297.4M | $220.8M | $145.2M | $114.3M | $147.2M | $165.3M | $77.8M | $86.5M | $62.7M | $53.6M |
| Free cash flow | $215.7M | $185.7M | $110.9M | $69.3M | $119.3M | $119.3M | -$360,000 | $23.2M | $24.1M | $20.8M |
| Cash & equivalents | $446.4M | $376.7M | $587.0M | $58.4M | $67.8M | $56.9M | $44.3M | $67.4M | $32.3M | $19.2M |
| Inventory | $333.7M | $306.1M | $303.9M | $266.0M | $221.9M | $198.0M | $225.7M | $197.5M | $155.3M | $120.7M |
| Total assets | $2.7B | $2.4B | $2.3B | $1.7B | $1.6B | $1.7B | $1.8B | $1.6B | $1.1B | $942.8M |
| Total liabilities | $1.1B | $1.0B | $1.1B | $519.6M | $608.5M | $705.8M | $807.4M | $687.2M | $435.5M | $444.6M |
| Shareholders' equity | $1.6B | $1.4B | $1.2B | $1.1B | $1.0B | $958.6M | $949.9M | $932.8M | $676.3M | $498.2M |
Growth · year-over-year · Revenue CAGR 10.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +11.8% | +7.9% | +9.2% | +7.1% | +11.5% | -3.1% | +12.7% | +21.3% | +20.5% | — |
| Net income growth | +6.8% | +27.5% | +26.7% | +53.8% | — | -280.6% | -87.0% | +52.7% | +36.8% | -15.5% |
| EPS growth | +4.9% | +25.3% | +25.6% | +53.6% | — | -280.0% | -87.2% | +41.8% | +22.2% | -15.1% |
| Free cash flow growth | +16.2% | +67.5% | +60.1% | -41.9% | +0.0% | — | -101.6% | -3.7% | +16.1% | +12.2% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.